ROBERT J HUGIN
CIK 1232505 · see remarks · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.32M
Companies
9
Total Filings
117
Lifetime Open-Market Net
-$160.24M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CB | Director | 21,851 | $328.14 | $7.17M | $0 | 7 | 2026-05-26 |
| BHVN | Director | 12,959 | $11.28 | $146.2K | $0 | 9 | 2025-05-07 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Director | 0 | — | — | $0 | 1 | 2022-10-03 |
| Allergan plc (AGN) Delisted | Director | 0 | — | — | $0 | 4 | 2020-05-11 |
| MEDICINES CO /DE (MDCO) Delisted | Director | 163,431 | — | — | $0 | 16 | 2017-11-13 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | 1,069,706 | — | — | -$70.81M | 50 | 2017-10-31 |
| DANAHER CORP /DE/ (DHRw) Delisted | Director | 3,576 | — | — | $0 | 3 | 2017-05-17 |
| CELGENE CORP /DE/ (CELG) Delisted | Chief Executive Officer | 735,014 | — | — | -$89.43M | 24 | 2010-10-14 |
| Coley Pharmaceutical Group, Inc. (COLY) Delisted | Director | — | — | — | $0 | 1 | 2007-06-15 |
Recent Filings · Page 3 of 12
117 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-02 | Allergan plc (AGN) Delisted | Mixed | +1,859 | $269.8K | EDGAR |
| 2019-02-20 | Allergan plc (AGN) Delisted | Grant (A) | +426 | $59.2K | EDGAR |
| 2017-11-13 | MEDICINES CO /DE (MDCO) Delisted | Exer (M) | +47,798 | $751.2K | EDGAR |
| 2017-10-31 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-26 | CELGENE CORP /DE/ (CELGZ) Delisted | Exer (M) | +62,020 | $1.97M | EDGAR |
| 2017-08-01 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +21,427 | -$3.09M | EDGAR |
| 2017-06-23 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +62,750 | -$10.29M | EDGAR |
| 2017-05-30 | MEDICINES CO /DE (MDCO) Delisted | Grant (A) | +3,237 | $0 | EDGAR |
| 2017-05-17 | DANAHER CORP /DE/ (DHRw) Delisted | Grant (A) | +990 | $0 | EDGAR |
| 2017-05-02 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.